Boston Scientific (BSX) Net Cash Flow Growth (5y) (2014 - 2026)
Boston Scientific (BSX) Net Cash Flow Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn |
| 2 | Stryker | 127.04 Bn | 123.56 Bn | 4.50 Bn |
| 3 | Medtronic | 118.81 Bn | 109.59 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.03 Bn | 47.78 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.03 Bn | 22.54 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.18 Bn | 18.77 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -27.60% |
| Mar 31, 2026 | -31.52% |
| Dec 31, 2025 | 33.75% |
| Sep 30, 2025 | 22.70% |
| Jun 30, 2025 | -16.40% |
| Mar 31, 2025 | 21.61% |
| Dec 31, 2024 | -90.53% |
| Sep 30, 2024 | 27.90% |
| Jun 30, 2024 | 58.05% |
| Mar 31, 2024 | -6.87% |
| Dec 31, 2023 | 11.71% |
| Sep 30, 2023 | 121.82% |
| Jun 30, 2023 | 3.72% |
| Mar 31, 2023 | -34.61% |
| Dec 31, 2022 | 13.83% |
| Sep 30, 2022 | -26.26% |
| Jun 30, 2022 | -19.53% |
| Mar 31, 2022 | -58.84% |
| Dec 31, 2021 | -44.57% |
| Sep 30, 2021 | -29.51% |